Banner

How one OD uses Oxervate for corneal healing

Article

There is treatment hope for neurotrophic keratitis, a rare disease affecting the cornea.

Scott Schachter, OD, reviews Oxervate, the first FDA-approved treatment for neurotrophic keratitis to exhibit complete corneal healing.

Related Videos
Brianna Rhue, OD, FAAO
Maria Richman, OD, FAAO, and Harvey Richman, OD, FAAO, FCOVD
Related Content

Handling comorbidities prior to surgery

September 26th 2023

Practical management EP 14: Your practice-purchase checklist

April 27th 2023

A funny thing happened at the office: Part 2

June 5th 2023

Practical management EP 13: Things to look for in a practice when purchasing

April 20th 2023

Silicon Valley Bank failure: What physicians need to know

May 4th 2023

New and emerging myopia management: The impact of sleep

May 3rd 2023

Handling comorbidities prior to surgery

September 26th 2023

Practical management EP 14: Your practice-purchase checklist

April 27th 2023

A funny thing happened at the office: Part 2

June 5th 2023

Practical management EP 13: Things to look for in a practice when purchasing

April 20th 2023

Silicon Valley Bank failure: What physicians need to know

May 4th 2023

New and emerging myopia management: The impact of sleep

May 3rd 2023

Handling comorbidities prior to surgery

September 26th 2023

Practical management EP 14: Your practice-purchase checklist

April 27th 2023

A funny thing happened at the office: Part 2

June 5th 2023

Practical management EP 13: Things to look for in a practice when purchasing

April 20th 2023

Silicon Valley Bank failure: What physicians need to know

May 4th 2023

New and emerging myopia management: The impact of sleep

May 3rd 2023
© 2023 MJH Life Sciences

All rights reserved.